Multiple MyelomaMy-eStEPsNCT04393090
eHealth for the Elderly
An observational study of Multiple Myeloma, run by Cankado GmbH at 8 sites in Germany.
Trial summary
Since internet usage as a complementing element in cancer care is becoming more and more important in oncological routine we launched My-eStEPs (eHealth Strategy for Elderly Patients with Multiple Myeloma) to investigate how specifically elderly patients and their Healthcare Professionals (HCPs) adopt electronic… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Multiple Myeloma
- What is being tested?
- eHealth platform CANKADO
- How many people
- 30 participants
- Where
- 8 sitesGermany
- Study dates
- Oct 2016to May 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: 30 patients (median age 75 years) suffering from multiple myeloma treated by oral IMiDs in 8 medical centers were asked to use the open eHealth platform CANKADO as a digital therapy-supporting tool.
Who may be able to join
- multiple myeloma patients
- treated by oral IMiDs
Who cannot join
- -
Trial locations and contacts
8 sites in 1 country.
8 sites in 1 country
Germany8 sites
Hämato-Onkologische Schwerpunktpraxis
Aschaffenburg, 63739
Onkologie-Köln,
Cologne, 50677
St.-Antonius-Hospital
Eschweiler, 52249
Praxis am Albertinen- Krankenhaus
Hamburg, 22457
Institut für Versorgungsforschung in der Onkologie GbR
Koblenz, 56068
Gemeinschaftspraxis für Hämatologie und Onkologie
Langen, 63225
Praxis Dr. med. Peter Ehscheidt, Facharzt für Innere Medizin, Hämatologie, Onkologie, Medikamentöse Tumortherapie und Palliativmedizin
Neuwied, 56564
Medicum
Wiesbaden, 65189
About this study
Official title: Multiple Myeloma Patients and Their HCPs Tested eHealth Support
Since internet usage as a complementing element in cancer care is becoming more and more important in oncological routine we launched My-eStEPs (eHealth Strategy for Elderly Patients with Multiple Myeloma) to investigate how specifically elderly patients and their Healthcare Professionals (HCPs) adopt electronic Health (eHealth) support during outpatient treatment. The purpose of this project is to explore how eHealth support influences patients' interaction with their HCPs and how both can benefit from this.
- Conditions
- Multiple Myeloma
- Being tested
- eHealth platform CANKADO
- Medical subject headings
- Multiple Myeloma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
eHealth platform CANKADOOther
The patients were asked to use the open eHealth platform CANKADO as a digital supporting tool.
What is being measured
The primary outcome is the main question the study is designed to answer.
Frequency of patient's internet use
Evaluated in the following criteria: daily, at least once per week, at least once per month, less than once per month
Measured: 3 months
Purpose of patient's internet use
Evaluated in the following criteria: news, online-banking, information collection about products, health-related topics, software downloads, dictionaries
Measured: 3 months
Patient's internet use for health-related topics
Evaluated in the following criteria: does the patient use the internet for health-related topics and if yes, for what exactly
Measured: 3 months
Patient's technical equipment
The presence of following equipment was evaluated: fixed network telephone, smartphone, internet-enabled computer, notebook, laptop, iPad and tablet ownership.
Measured: 3 months
eHealth usage satisfaction
By a structured interview with the patients about their user satisfaction (graded between 1 (best) and 5 (worst))
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2020
- Study startOct 2016
- Primary completionMay 2017
- Study completionMay 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Multiple MyelomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cankado GmbH
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Timo Schinköthe, PhD, Study director, Cankado GmbH
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04393090
- Sponsor's protocol ID
- CAN-17-01
- Acronym
- My-eStEPs
- Status last verified
- May 2020
- First submitted
- 4 May 2020
- Last updated
- 19 May 2020
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multiple Myeloma Patients and Their HCPs Tested eHealth Support
- ClinicalTrials.gov ID
- NCT04393090
- Acronym / sponsor ID
- My-eStEPs / CAN-17-01
- Conditions
- Multiple Myeloma
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Cankado GmbHIndustry (pharma, biotech, devices)
- Study start
- Oct 2016 (actual)
- Primary completion
- May 2017 (actual)
- Study completion
- May 2017 (actual)
- First posted
- 19 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Since internet usage as a complementing element in cancer care is becoming more and more important in oncological routine we launched My-eStEPs (eHealth Strategy for Elderly Patients with Multiple Myeloma) to investigate how specifically elderly patients and their Healthcare Professionals (HCPs) adopt electronic Health (eHealth) support during outpatient treatment. The purpose of this project is to explore how eHealth support influences patients' interaction with their HCPs and how both can benefit from this.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- 30 patients (median age 75 years) suffering from multiple myeloma treated by oral IMiDs in 8 medical centers were asked to use the open eHealth platform CANKADO as a digital therapy-supporting tool.
Key inclusion criteria (2 listed)
- multiple myeloma patients
- treated by oral IMiDs
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| eHealth platform CANKADOThe patients were asked to use the open eHealth platform CANKADO as a digital supporting tool. | Other | – |
Primary outcome
Frequency of patient's internet use
Time frame: 3 months
Evaluated in the following criteria: daily, at least once per week, at least once per month, less than once per month
Purpose of patient's internet use
Time frame: 3 months
Evaluated in the following criteria: news, online-banking, information collection about products, health-related topics, software downloads, dictionaries
Patient's internet use for health-related topics
Time frame: 3 months
Evaluated in the following criteria: does the patient use the internet for health-related topics and if yes, for what exactly
Patient's technical equipment
Time frame: 3 months
The presence of following equipment was evaluated: fixed network telephone, smartphone, internet-enabled computer, notebook, laptop, iPad and tablet ownership.
eHealth usage satisfaction
Time frame: 3 months
By a structured interview with the patients about their user satisfaction (graded between 1 (best) and 5 (worst))
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2020.
Related trials for Multiple Myeloma
Recruiting
HEME Home Transfusion Program
Leukemia, Myeloma
RecruitingPhase 2
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Not yet recruitingPhase 2
Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
RecruitingObservational study
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
RecruitingObservational study
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Chronic Myeloproliferative Disorders, Leukemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Timo Schinköthe, PhD study director
Cankado GmbH
8 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Multiple Myeloma, run by Cankado GmbH at 8 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Frequency of patient's internet use (time frame: 3 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2020.